Article Details

2022-12-10 | NDAQ:FATE | Press Release | Fate Therapeutics Inc. - Stockhouse

Retrieved on: 2022-12-10 20:17:47

Tags for this article:

Click the tags to see associated articles and topics

2022-12-10 | NDAQ:FATE | Press Release | Fate Therapeutics Inc. - Stockhouse. View article details on hiswai:

Excerpt

... non-cleavable CD16 (hnCD16) Fc receptor to maximize antibody-dependent ... cells through combination with monoclonal antibody (mAb) therapy.

Article found on: stockhouse.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up